Showing results (1-10 of 317) with videos related to

Sort By:
Pageof 32
Frontiers in Aging Neuroscience|September 19, 2012
Characterizing healthy samples for studies of human cognitive agingDavid S Geldmacher, Bonnie E Levin, Clinton B Wright
Frontiers in Aging Neuroscience|September 19, 2012
Challenges and opportunities for characterizing cognitive aging across speciesErik D Roberson, R Anthony Defazio, Carol A Barnes, et al.
Journal of the International Neuropsychological Society : JINS|November 11, 2014
Modeling metabolic syndrome and its association with cognition: the Northern Manhattan studyBonnie E Levin, Maria M Llabre, Chuanhui Dong, et al.
Frontiers in Bioscience : a Journal and Virtual Library|September 6, 2003
Visuospatial dysfunction in the neurodegenerative diseasesDavid S Geldmacher
Neuropsychiatric Disease and Treatment|October 3, 2008
Cost-effectiveness of drug therapies for Alzheimer's disease: A brief reviewDavid S Geldmacher
Primary Care Companion to the Journal of Clinical Psychiatry|June 24, 2004
Long-Term Cholinesterase Inhibitor Therapy for Alzheimer's Disease: Practical Considerations for the Primary Care PhysicianDavid S. Geldmacher
Primary Care Companion to the Journal of Clinical Psychiatry|July 4, 2007
Treatment guidelines for Alzheimer's disease: redefining perceptions in primary careDavid S Geldmacher
Continuum (Minneapolis, Minn.)|December 2, 2024
Treatment of Alzheimer DiseaseDavid S Geldmacher
Seminars in Neurology|August 10, 2002
Cost-effective recognition and diagnosis of dementiaDavid S Geldmacher
Managed Care (Langhorne, Pa.)|January 13, 2006
The cost benefit to health plans of pharmacotherapy for Alzheimer's diseaseDavid S Geldmacher
Pageof 32